What is (+/-)-Oxamniquine used for?

(+/-)-Oxamniquine is indicated for Infection by Schistosoma.

What development phase is (+/-)-Oxamniquine in?

(+/-)-Oxamniquine is FDA-approved (marketed).

What is the generic name of (+/-)-Oxamniquine?

OXAMNIQUINE is the generic (nonproprietary) name of (+/-)-Oxamniquine.

Last reviewed 2026-04-20 · How we verify

(+/-)-Oxamniquine (OXAMNIQUINE)

FDA-approved approved Small molecule Quality 10/100

Oxamniquine is a small molecule anthelmintic drug originally developed by and currently owned by a pharmaceutical company. It is used to treat infections caused by Schistosoma, a type of parasitic flatworm. The drug was FDA approved in 1980 and is now off-patent, meaning it is available as a generic medication. Oxamniquine works by interfering with the parasite's ability to reproduce, ultimately leading to its death. As an off-patent medication, it is widely available and used to treat schistosomiasis.

At a glance

Generic name	OXAMNIQUINE
Drug class	Anthelmintic
Modality	Small molecule
Therapeutic area	Infectious Disease
Phase	FDA-approved
First approval	1980

Approved indications

Infection by Schistosoma

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

(+/-)-Oxamniquine CI brief — competitive landscape report
(+/-)-Oxamniquine updates RSS · CI watch RSS